FDA recall D-0270-2021

Areva Pharmaceuticals Inc · Class II · drug

Product

Irinotecan Hydrochloride Injection, USP, 40 mg/2 mL (20 mg/mL), 2 mL Single-Dose Vial, Rx Only, Distributed by: Areva Pharmaceuticals, Inc., Gerogetown, IN 47122, Made in India, NDC 59923-714-02.

Reason for recall

CGMP Deviations: based on a Warning Letter received by the manufacturer of the recalled product for inadequate out-of specification investigations, complaint and the investigation conclusions.

Distribution

Nationwide in the USA

Key facts

Status
Terminated
Initiation date
2020-11-19
Report date
2021-03-03
Termination date
2022-12-28
Voluntary/Mandated
Voluntary: Firm initiated
Location
Georgetown, IN, United States

Primary source

https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0270-2021